High-Dose Lipitor Is As Safe As Lower Doses, Pfizer Analysis Finds
Executive Summary
Treatment-related adverse events for Lipitor 80 mg were similar to those for atorvastatin 10 mg, according to a Pfizer analysis of pooled studies of the cholesterol-lowering drug reported in the January issue of the American Journal of Cardiology
You may also be interested in...
Lipitor Adds Claims For High-Dose Use From TNT, IDEAL – But Label Is Mixed
Lipitor (atorvastatin) has gained approval for five new indications based on the Treating to New Targets and Incremental Decrease in Endpoints Through Aggressive Lipid Lowering studies, but the updated labeling includes mixed statements about the benefits of treatment with higher doses of atorvastatin
Lipitor Adds Claims For High-Dose Use From TNT, IDEAL – But Label Is Mixed
Lipitor (atorvastatin) has gained approval for five new indications based on the Treating to New Targets and Incremental Decrease in Endpoints Through Aggressive Lipid Lowering studies, but the updated labeling includes mixed statements about the benefits of treatment with higher doses of atorvastatin
High-Dose Statins IDEAL For Use In High-Risk Patients, Study Suggests
Results of the IDEAL study support the aggressive use of high-dose statins as standard therapy for patients at high risk of repeat cardiovascular events, Scott Grundy (University of Texas Southwestern Medical Center) told the American Heart Association annual meeting Nov. 15 in Dallas